Study uncovers stem cells’ ability to restore immunity and repair gut damage caused by HIV
Research from the UNC School of Medicine lab of Jenny Ting, PhD, shows that the widely used drug metformin reduces metabolism of infected T cells to suppress HIV replication.
A recent study published in the journal Nature Medicine, led by researchers Todd Allen, PhD, a professor of Medicine at Harvard Medical School (HMS) and group leader at the Ragon Institute of MGH, MIT and Harvard, and Jim Riley, PhD, a professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, describes a new Dual CAR T cell immunotherapy that can help fight HIV infection. The paper's first authors are Colby Maldini, a graduate student at the University of Pennsylvania and Daniel Claiborne, PhD, a research fellow at the Ragon Institute.
Most vaccines direct the adaptive immune system to fight off infections with one arm tied behind its back. A new study in monkeys untied the other arm.
NIH researchers, international collaborators report results of small, open-label study
A new injectable HIV drug could mean that patients no longer have to medicate themselves on a daily basis, according to a clinical trial led by researchers from Queen Mary University of London and Barts Health NHS Trust, and sponsored by Viiv healthcare.